Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8168784 Processes to make apoptosis promoters

Patent 8168784 was granted and assigned to Abbott on May, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Abbott

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8168784

Patent Inventor Names

David R. Hill0

Anthony Ralph Haight0

Shashank Shekhar0

Su Yu0

Thaddeus Stephan Franczyk, II0

Jianzhang Mei0

Lei Wang0

Maureen Ann McLaughlin0

Date of Patent

May 1, 2012

Patent Application Number

12486361

Date Filed

June 17, 2009

Patent Citations Received

‌

US Patent 11963957 Treating cardiovascular disease by selectively eliminating senescent cells

‌

US Patent 11980616 Treating liver disease by selectively eliminating senescent cells

Patent Primary Examiner

‌

Rebecca Anderson

Patent abstract

Processes to make compounds, including N-acylsulfonamide apoptosis promoters are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8168784 Processes to make apoptosis promoters

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API